Acura Pharmaceuticals expands Amended Loan Schedule to $11.3M
Acura Pharmaceuticals increasing aggregate secured debt facility via amendments to November 2022 promissory notes. Market implication for biotech leverage and cash flow management.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed